BACILLIGEN

bacilligen-logo

Bacilligen, Inc. is an early stage R&D Company focused on manufacturing treatments and vaccines for the oncology and infectious disease markets. Founded in March 2006, Drs. David Hone and Steve Bende, who collectively have invested 40 years into research and vaccine design, became dedicated to advancing medical technology in developing innovative solutions for cancer and infectious diseases.

#SimilarOrganizations #People #Website #More

BACILLIGEN

Industry:
Biotechnology Health Care

Founded:
2006-03-01

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.bacilligen.com

Status:
Active

Contact:
301-217-9525

Email Addresses:
[email protected]

Technology used in webpage:
Person Schema U.S. Server Location Thing Schema Google Plus One Platform


Similar Organizations

escape-therapeutics-logo

Escape Therapeutics

Escape Therapeutics is an early stage biotechnology company

exolytics-logo

ExoLytics

ExoLytics is an early-stage biotechnology company.

iaso-biomed-logo

Iaso BioMed

Iaso BioMed is a developmental stage biotechnology company

Current Employees Featured

steve-bende_image

Steve Bende
Steve Bende President & CEO @ Bacilligen
President & CEO

Official Site Inspections

http://www.bacilligen.com

Unable to get host informations!!!

Loading ...

More informations about "Bacilligen"

Bacilligen - Crunchbase Company Profile & Funding

Bacilligen, Inc. is an early stage R&D Company focused on manufacturing treatments and vaccines for the oncology and infectious disease markets. Founded in March 2006, Drs. David …See details»

Bacilligen 2025 Company Profile: Valuation, Funding & Investors

Bacilligen General Information Description. Developer of proprietary vector system for vaccine production. The company has developed a novel platform for rapid on-demand biological …See details»

Firm | SBIR

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means …See details»

Bacilligen - Contacts, Employees, Board Members, Advisors

Bacilligen is an early-stage Biotechnology Company. Experience the new Crunchbase, powered by AISee details»

Bacilligen - Overview, News & Similar companies | ZoomInfo.com

Who is Bacilligen. Bacilligen, Inc. is a privately-held, early-stage biotechnology company developing vaccines infectious diseases indications and improved technology for biological …See details»

Bacilligen, Inc - VentureRadar

Find out more about Bacilligen, Inc including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. Homepage …See details»

Bacilligen, Inc | (301) 217-9525 | Rockville, Maryland - AllBiz

Bacilligen, Inc is located in Rockville, Maryland, and was founded in 2006. At this location, Bacilligen, Inc employs approximately 2 people. This business is working in the following …See details»

Bacilligen - Profiles & Contacts - Crunchbase

Bacilligen is an early-stage Biotechnology CompanySee details»

Bacilligen - News & Analysis - Crunchbase

Bacilligen is an early-stage Biotechnology Company. New. ResourcesSee details»

BACILLIGEN INC Potomac MD, 20850 - Company Profile - Cortera

Free Business profile for BACILLIGEN INC at 9700 Great Seneca Hwy, Potomac, MD, 20850-3307, US. BACILLIGEN INC specializes in: Commercial Physical and Biological Research. …See details»

Award | SBIR

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... BACILLIGEN, INC. BACILLIGEN, …See details»

Bacilligen - Growth Outlook - Crunchbase

Bacilligen is an early-stage Biotechnology Company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»

Bacilligen, Inc. Receives Investment from Maryland ... - BioSpace

Jun 27, 2007 ROCKVILLE, Md.--(BUSINESS WIRE)--Bacilligen, Inc., an early-stage Biotechnology Company in Rockville, announced today that the Company has accepted a …See details»

BioCentury - Bacilligen: Building on bacteria

Mar 24, 2008 Bacilligen Inc.. has three bacteria-based technology platforms that it believes confer safety, efficacy and manufacturing advantages when developing vaccines and …See details»

Bacilligen Inc. - BioCentury Company Profiles - BCIQ

Bacilligen Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Research programme: infectious diseases vaccines - Bacilligen

Bacilligen is developing vaccine against infectious diseases based on its proprietary Bacilligen Vector System (BVS) vaccine vector platform, initially forSee details»

Bacilligen - Tech Details - Crunchbase

Bacilligen is actively using 3 technologies for its website, according to BuiltWith. These include Person Schema, Thing Schema, and Google Plus One Platform. This year, Bacilligen is …See details»

Research programme: recombinant mycobacteria - Bacilligen

Bacilligen Inc is developing a recombinant version of the mycobacterium bovis (BCG) vaccine, for the treatment and prevention of reccurence of superficial Skip to main content. Research …See details»

Bacilligen - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Bacilligen is an early-stage Biotechnology Company. Start Free Trial . Chrome ExtensionSee details»

Patents Assigned to BACILLIGEN, INC. - Justia Patents Search

Patents Assigned to BACILLIGEN, INC. Replication-proficient dsRNA capsids and uses thereof. Publication number: 20100322951 Abstract: Compositions and methods useful in the …See details»

linkstock.net © 2022. All rights reserved